5[5]Chaudhari U, Romano P, Mulcahy LD,et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised tril[J]. Lancet,2001,357(9271 ): 1842～1847.
6[6]Mease PJ, Goffe BS,Metz J,et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial[J]. Lancet, 2000,356 (9227): 385～390.
7[7]Bachelez H, Flageul B, Dubertret L, et al. Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4[J]. J Autoimmun, 1998,11 (1): 53～62.
8[8]Krueger JG, Walters IB, Miyazawa M, et al. Successful in vivo blockade of CD25(high-affinity interleukin 2 receptor)on Tcells by administration of humanized anti-Tac antibody to patients with psoriasis[J] .J Am Acad Dermatol, 2000,43 (3): 448～458.
9[9]Gottlieb A, Krueger JG, Bright R,et al. Effects of administration of a single dose of a humanized monoclonal antibody to CDlla on the immunobiology and clinical activity of psoriasis[J]. J Am Acad Dermatol, 2000,42(3):428～443.
10[10]Martin A, Gutierrez E, Muglia J, et al. A multicenter doseescalation trial with denileukin diftitox(ONTAK, DAB (389) IL-2) in patients with severe psoriasis[J]. J Am Acad Dermatol,2001,45(6) :871～881.
